Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0539) | |||||
|---|---|---|---|---|---|
| DME Name | Nicotinate-nucleotide adenylyltransferase 2 (NMNAT2), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 2.7.7.1 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Lymphoma | Moderate hypomethylation | |||
| Interaction Name | DNMT-NMNAT2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 1.75E-09; delta-beta: -2.68E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the NMNAT2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Nicotinate-nucleotide adenylyltransferase 2. As a result, the interaction between DNMT and NMNAT2 can moderatly affect the drug-metabolizing process of Nicotinate-nucleotide adenylyltransferase 2. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2C30 Melanoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| Histone modification | |||||
| Histone deacetylases (HDACs) | Melanoma | Repression | |||
| Uniprot ID | |||||
| Interaction Name | HDACs-NMNAT2 interaction | [1] | |||
| Studied Cell Lines | SK-MEL-3 cell line | ||||
| Description | Histone deacetylases (HDACs) are reported to deacetylate the NMNAT2 gene and thereby repress the transcriptional activity of the drug-metabolizing enzyme Nicotinate-nucleotide adenylyltransferase 2. As a result, the interaction between HDACs and NMNAT2 can inhibit the drug-metabolizing process of Nicotinate-nucleotide adenylyltransferase 2. | ||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. Cancer Genomics Proteomics. Sep-Oct 2018;15(5):349-364. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

